Physician

Christopher Droogan, DO

According to 2025 Medicare claims, Christopher Droogan, DO (NPI: 1174528129) practices advanced heart failure and transplant cardiology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is MAIN LINE HEALTHCARE (NPI: 1922077643; TIN: 232359401) and primary practice location at 19096-3450. Droogan is affiliated with the Delaware Valley ACO (ACO ID: A2024), participating under the MSSP model.

Droogan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 785 traditional Medicare patients, billed 2,201 HCPCS/CPT codes, and received $138,265 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 3,943 prescription claims across 571 beneficiaries totaling $597,082 in drug costs, led by Eliquis (Apixaban). DME data shows 33 claims. Open Payments data shows 46 records totaling $30,994. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $210,630 to $138,265. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	806	3,326	$210,630
2016	913	3,658	$235,028
2017	928	3,414	$228,590
2018	895	3,149	$214,101
2019	999	3,367	$245,016
2020	852	2,636	$183,744
2021	825	2,776	$180,638
2022	807	2,592	$168,467
2023	829	2,439	$162,728
2024	785	2,201	$138,265

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	462	5,461	$433,496
2016	507	5,998	$506,176
2017	501	5,792	$513,411
2018	508	5,345	$488,006
2019	550	5,073	$567,677
2020	529	4,980	$571,435
2021	525	4,504	$530,244
2022	516	3,942	$545,935
2023	522	3,609	$536,467
2024	571	3,943	$597,082

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	69	$52,839
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	24	$985
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	33	$1,679

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	89	202	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	355	437	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	83	87	$65
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	165	166	$52
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	475	620	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	198	12,438	$236,770
Jardiance	Empagliflozin	91	5,830	$108,095
Entresto	Sacubitril/Valsartan	69	4,250	$85,869
Xarelto	Rivaroxaban	49	3,810	$68,088
Atorvastatin Calcium	Atorvastatin Calcium	561	47,206	$8,819

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	11	$1,200
J2260	Injection, milrinone lactate, 5 mg	N	N/R	11	$268
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	11	$211

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$29,144	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$1,850	Abbott Laboratories
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Droogan, DO?

Tedicare shows public-source Medicare data for Christopher Droogan, DO (NPI 1174528129), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Droogan, DO have ACO affiliation data?

Christopher Droogan, DO is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024).

What billing organization is linked to Christopher Droogan, DO?

Christopher Droogan, DO is linked to MAIN LINE HEALTHCARE (billing NPI 1922077643) in the available physician profile data.

Does Christopher Droogan, DO have Open Payments data?

Christopher Droogan, DO has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.